File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Role of Biological Mediators of Tumor-Associated Macrophages in Breast Cancer Progression

TitleRole of Biological Mediators of Tumor-Associated Macrophages in Breast Cancer Progression
Authors
Keywordsbiological mediators
breast cancer
breast cancer
TAM-targeted therapy
tumor microenvironment
Tumor-associated macrophages
Issue Date22-Nov-2022
PublisherBentham Science Publishers
Citation
Current Medicinal Chemistry, 2022, v. 29, n. 33, p. 5420-5440 How to Cite?
Abstract

Background: Breast cancer (BRCA) has become the most common cancer worldwide. The tumor microenvironment (TME) in the breast exerts a crucial role in promoting BRCA initiation, progression, and metastasis. Tumor-associated macrophages (TAMs) are the primary component of tumor-infiltrating immune cells through biological mediators that convert TME into malignant tumors. Combinations of these biological mediators can promote tumor growth, metastasis, angiogenesis, and immune suppression and limit the anti-tumor activity of conventional chemotherapy and radiotherapy.

Objectives: The present study aimed to highlight the functions of several biological mediators in the breast thatgenerate TME into malignant tumors. Furthermore, this review offers a rationale for TAM-targeted therapy as a novel treatment strategy for BRCA.

Results: This review emphasizes TAM-associated biological mediators of TME, viz., cancer- associated fibroblasts, endothelial cells, adipocytes, tumor-derived exosomes, extracellular matrix, and other immune cells, which facilitate TME in malignant tumors. Evidence suggests that the increased infiltration of TAMs and elevated expression of TAMrelated genes are associated with a poor prognosis of BRCA. Based on these findings, TAM-targeted therapeutic strategies, including inhibitors of CSF-1/CSF-1R, CCL2/CCR2, CCL5-CCR5, bisphosphonate, nanoparticle, and exosomal-targeted delivery have been developed, and are currently being employed in intervention trials.

Conclusion: This review concludes the roles of biological mediators of TME that interact with TAMs in BRCA, providing a rationale for TAM-targeted therapy as a novel treatment approach for BRCA.


Persistent Identifierhttp://hdl.handle.net/10722/339112
ISSN
2023 Impact Factor: 3.5
2023 SCImago Journal Rankings: 0.759
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLi, Yan-
dc.contributor.authorGanesan, Kumar-
dc.contributor.authorChen, Jianping-
dc.date.accessioned2024-03-11T10:33:59Z-
dc.date.available2024-03-11T10:33:59Z-
dc.date.issued2022-11-22-
dc.identifier.citationCurrent Medicinal Chemistry, 2022, v. 29, n. 33, p. 5420-5440-
dc.identifier.issn0929-8673-
dc.identifier.urihttp://hdl.handle.net/10722/339112-
dc.description.abstract<p>Background: Breast cancer (BRCA) has become the most common cancer worldwide. The tumor microenvironment (TME) in the breast exerts a crucial role in promoting BRCA initiation, progression, and metastasis. Tumor-associated macrophages (TAMs) are the primary component of tumor-infiltrating immune cells through biological mediators that convert TME into malignant tumors. Combinations of these biological mediators can promote tumor growth, metastasis, angiogenesis, and immune suppression and limit the anti-tumor activity of conventional chemotherapy and radiotherapy.</p><p>Objectives: The present study aimed to highlight the functions of several biological mediators in the breast thatgenerate TME into malignant tumors. Furthermore, this review offers a rationale for TAM-targeted therapy as a novel treatment strategy for BRCA.</p><p>Results: This review emphasizes TAM-associated biological mediators of TME, viz., cancer- associated fibroblasts, endothelial cells, adipocytes, tumor-derived exosomes, extracellular matrix, and other immune cells, which facilitate TME in malignant tumors. Evidence suggests that the increased infiltration of TAMs and elevated expression of TAMrelated genes are associated with a poor prognosis of BRCA. Based on these findings, TAM-targeted therapeutic strategies, including inhibitors of CSF-1/CSF-1R, CCL2/CCR2, CCL5-CCR5, bisphosphonate, nanoparticle, and exosomal-targeted delivery have been developed, and are currently being employed in intervention trials.</p><p>Conclusion: This review concludes the roles of biological mediators of TME that interact with TAMs in BRCA, providing a rationale for TAM-targeted therapy as a novel treatment approach for BRCA.</p>-
dc.languageeng-
dc.publisherBentham Science Publishers-
dc.relation.ispartofCurrent Medicinal Chemistry-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectbiological mediators-
dc.subjectbreast cancer-
dc.subjectbreast cancer-
dc.subjectTAM-targeted therapy-
dc.subjecttumor microenvironment-
dc.subjectTumor-associated macrophages-
dc.titleRole of Biological Mediators of Tumor-Associated Macrophages in Breast Cancer Progression-
dc.typeArticle-
dc.identifier.doi10.2174/0929867329666220520121711-
dc.identifier.scopuseid_2-s2.0-85137872859-
dc.identifier.volume29-
dc.identifier.issue33-
dc.identifier.spage5420-
dc.identifier.epage5440-
dc.identifier.eissn1875-533X-
dc.identifier.isiWOS:000854464900004-
dc.identifier.issnl0929-8673-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats